Sven Schaffer News Today

Illumina will provide Hannover Medical School with reagents for library preparation and whole-genome sequencing for up to 100 parent-child trios.

The company will support a 500-patient study of genomic profiling for cancer therapy selection with sequencing reagents and other resources.  

German program using whole genome sequencing to diagnose rare diseases and cancer risk A program at the University Hospital of Tübingen is the first in Germany to use whole genome sequencing (WGS) to improve the diagnosis of rare diseases and hereditary cancers. The program is led by Professors Tobias Haack and Olaf Riess from the Institute of Medical Genetics and Applied Genomics. While they will use whole genomes to diagnose rare conditions, they will also use ...